Literature DB >> 26194110

Comparison of microperc and mini-percutaneous nephrolithotomy for medium-sized lower calyx stones.

Adem Tok1,2, Fatih Akbulut3, Ibrahim Buldu4, Tuna Karatag4, Onur Kucuktopcu3, Gokhan Gurbuz3, Okan Istanbulluoglu4, Abdullah Armagan5, Abdulkadir Tepeler5, Ali Ihsan Tasci5.   

Abstract

The objective of this study was to present the outcomes of comparative clinical study of microperc versus mini-percutaneous nephrolithotomy (mini-PNL) in the treatment of lower calyx stones of 10-20 mm. Patients with lower calyx stones treated with microperc (Group-1) or mini-PNL (Group-2) between 2011 and 2014 were retrospectively analyzed. Demographics of the patients were compared, including age, gender, BMI, stone size, laterality and procedural parameters (operation and fluoroscopy time), and outcomes (success and complication rates). A total of 98 patients were evaluated, assigned to Group-1 (n = 58) and to Group-2 (n = 40). Groups were statistically similar in terms of age, stone size, and BMI (p = 0.3, 0.07, 0.6, respectively). The mean procedure and fluoroscopy duration for Group-1 were 43.02 ± 27.98 min and 112.05 ± 72.5 s, and 52.25 ± 23.09 min and 138.53 ± 56.39 s in Group-2 (p = 0.006 and 0.006). The mean hematocrit drop was significantly higher in Group-2 compared to Group-1 (3.98 vs. 1.96%; p < 0.001); however, none of the cases required blood transfusion. Overall complication rates exhibited no statistically significant difference (p = 0.57). Stone-free status was similar (86.2 vs. 82.5%, p = 0.66). The tubeless procedure rate was significantly higher in Group-1 (p < 0.001). In Group-2, duration of hospitalization was significantly longer than in Group-1 (2.63 vs. 1.55 days; p < 0.01). Outcomes of the present retrospective study show that microperc is a treatment option for medium-sized lower calyx stone, being associated with lower blood loss, procedure, reduced fluoroscopy and hospitalization time, and a higher tubeless rate.

Entities:  

Keywords:  Efficacy; Medium-size lower pole kidney stone; Micro-percutaneous nephrolithotomy; Mini-percutaneous nephrolithotomy; Safety

Mesh:

Year:  2015        PMID: 26194110     DOI: 10.1007/s00240-015-0804-2

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  17 in total

1.  Lower pole I: a prospective randomized trial of extracorporeal shock wave lithotripsy and percutaneous nephrostolithotomy for lower pole nephrolithiasis-initial results.

Authors:  D M Albala; D G Assimos; R V Clayman; J D Denstedt; M Grasso; J Gutierrez-Aceves; R I Kahn; R J Leveillee; J E Lingeman; J N Macaluso; L C Munch; S Y Nakada; R C Newman; M S Pearle; G M Preminger; J Teichman; J R Woods
Journal:  J Urol       Date:  2001-12       Impact factor: 7.450

2.  The role of microperc in the treatment of symptomatic lower pole renal calculi.

Authors:  Abdulkadir Tepeler; Abdullah Armagan; Ahmet Ali Sancaktutar; Mesrur Selcuk Silay; Necmettin Penbegul; Tolga Akman; Namık Kemal Hatipoglu; Cevper Ersoz; Mehmet Remzi Erdem; Muzaffer Akcay
Journal:  J Endourol       Date:  2012-10-25       Impact factor: 2.942

3.  The impact of pelvicaliceal anatomy on the success of retrograde intrarenal surgery in patients with lower pole renal stones.

Authors:  Berkan Resorlu; Ural Oguz; Eylem Burcu Resorlu; Derya Oztuna; Ali Unsal
Journal:  Urology       Date:  2012-01       Impact factor: 2.649

4.  Lower caliceal stone clearance after shock wave lithotripsy or ureteroscopy: the impact of lower pole radiographic anatomy.

Authors:  A M Elbahnasy; A L Shalhav; D M Hoenig; O M Elashry; D S Smith; E M McDougall; R V Clayman
Journal:  J Urol       Date:  1998-03       Impact factor: 7.450

5.  The Hickman peel-away sheath: alternative for pediatric percutaneous nephrolithotomy.

Authors:  M Helal; T Black; J Lockhart; T E Figueroa
Journal:  J Endourol       Date:  1997-06       Impact factor: 2.942

6.  Limitations of extracorporeal shockwave lithotripsy for lower caliceal stones: anatomic insight.

Authors:  F J Sampaio; A H Aragao
Journal:  J Endourol       Date:  1994-08       Impact factor: 2.942

Review 7.  Systematic review and meta-analysis of the clinical effectiveness of shock wave lithotripsy, retrograde intrarenal surgery, and percutaneous nephrolithotomy for lower-pole renal stones.

Authors:  James F Donaldson; Michael Lardas; Duncan Scrimgeour; Fiona Stewart; Steven MacLennan; Thomas B L Lam; Samuel McClinton
Journal:  Eur Urol       Date:  2014-10-23       Impact factor: 20.096

8.  Prospective, randomized trial comparing shock wave lithotripsy and ureteroscopy for lower pole caliceal calculi 1 cm or less.

Authors:  Margaret S Pearle; James E Lingeman; Raymond Leveillee; Ramsay Kuo; Glenn M Preminger; Robert B Nadler; Joseph Macaluso; Manoj Monga; Udaya Kumar; John Dushinski; David M Albala; J Stuart Wolf; Dean Assimos; Michael Fabrizio; Larry C Munch; Stephen Y Nakada; Brian Auge; John Honey; Kenneth Ogan; John Pattaras; Elspeth M McDougall; Timothy D Averch; Thomas Turk; Paul Pietrow; Stephanie Watkins
Journal:  J Urol       Date:  2005-06       Impact factor: 7.450

9.  Contemporary Management of Medium-Sized (10-20 mm) Renal Stones: A Retrospective Multicenter Observational Study.

Authors:  Murat Can Kiremit; Selcuk Guven; Kemal Sarica; Ahmet Ozturk; Ibrahim Buldu; Alper Kafkasli; Mehmet Balasar; Okan Istanbulluoglu; Rahim Horuz; Cihangir Ali Cetinel; Abdulkadir Kandemir; Selami Albayrak
Journal:  J Endourol       Date:  2015-03-06       Impact factor: 2.942

10.  Comparison of percutaneous nephrolithotomy, shock wave lithotripsy, and retrograde intrarenal surgery for lower pole renal calculi 10-20 mm.

Authors:  Ufuk Ozturk; Nevzat Can Sener; H N Goksel Goktug; Ismail Nalbant; Adnan Gucuk; M Abdurrahim Imamoglu
Journal:  Urol Int       Date:  2013-06-28       Impact factor: 2.089

View more
  1 in total

Review 1.  "Microperc" micropercutaneous nephrolithotomy: a review of the literature.

Authors:  Arvind P Ganpule; Jaspreet Chabra; Mahesh R Desai
Journal:  Urolithiasis       Date:  2017-12-07       Impact factor: 3.436

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.